Table of Contents
1 Parkinson’s Disease Treatment Market Overview
1.1 Product Overview and Scope of Parkinson’s Disease Treatment
1.2 Classification of Parkinson’s Disease Treatment by Types
1.2.1 Global Parkinson’s Disease Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Parkinson’s Disease Treatment Revenue Market Share by Types in 2018
1.2.3 Oral
1.2.4 Transdermal
1.2.5 Subcutaneous
1.2.6 Intestinal Infusion
1.3 Global Parkinson’s Disease Treatment Market by Application
1.3.1 Global Parkinson’s Disease Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Parkinson’s Disease Treatment Market by Regions
1.4.1 Global Parkinson’s Disease Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Parkinson’s Disease Treatment (2014-2024)
2 Company Profiles
2.1 UCB
2.1.1 Business Overview
2.1.2 Parkinson’s Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 AbbVie
2.2.1 Business Overview
2.2.2 Parkinson’s Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AbbVie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Acorda Therapeutics
2.3.1 Business Overview
2.3.2 Parkinson’s Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Acorda Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Roche
2.4.1 Business Overview
2.4.2 Parkinson’s Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teva
2.5.1 Business Overview
2.5.2 Parkinson’s Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Prothena
2.6.1 Business Overview
2.6.2 Parkinson’s Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Prothena Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Orion Pharmaceuticals
2.7.1 Business Overview
2.7.2 Parkinson’s Disease Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Impax Pharmaceuticals
2.8.1 Business Overview
2.8.2 Parkinson’s Disease Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Voyager Therapeutics
2.9.1 Business Overview
2.9.2 Parkinson’s Disease Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Voyager Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 MSD
2.10.1 Business Overview
2.10.2 Parkinson’s Disease Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 MSD Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 Sunovion
2.11.1 Business Overview
2.11.2 Parkinson’s Disease Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sunovion Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.12 Intec Pharma
2.12.1 Business Overview
2.12.2 Parkinson’s Disease Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Intec Pharma Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.13 GSK
2.13.1 Business Overview
2.13.2 Parkinson’s Disease Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 GSK Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.14 Acadia
2.14.1 Business Overview
2.14.2 Parkinson’s Disease Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Acadia Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.15 NeuroDerm
2.15.1 Business Overview
2.15.2 Parkinson’s Disease Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 NeuroDerm Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.16 Adamas Therapeutics
2.16.1 Business Overview
2.16.2 Parkinson’s Disease Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Adamas Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Parkinson’s Disease Treatment Market Competition, by Players
3.1 Global Parkinson’s Disease Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Parkinson’s Disease Treatment Players Market Share
3.2.2 Top 10 Parkinson’s Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Parkinson’s Disease Treatment Market Size by Regions
4.1 Global Parkinson’s Disease Treatment Revenue and Market Share by Regions
4.2 North America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
5 North America Parkinson’s Disease Treatment Revenue by Countries
5.1 North America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
5.2 USA Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6 Europe Parkinson’s Disease Treatment Revenue by Countries
6.1 Europe Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
6.2 Germany Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.4 France Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries
7.1 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
7.2 China Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.5 India Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
8 South America Parkinson’s Disease Treatment Revenue by Countries
8.1 South America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
8.2 Brazil Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Parkinson’s Disease Treatment by Countries
9.1 Middle East and Africa Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
10 Global Parkinson’s Disease Treatment Market Segment by Type
10.1 Global Parkinson’s Disease Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Parkinson’s Disease Treatment Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2014-2024)
10.4 Transdermal Revenue Growth Rate (2014-2024)
10.5 Subcutaneous Revenue Growth Rate (2014-2024)
10.6 Intestinal Infusion Revenue Growth Rate (2014-2024)
11 Global Parkinson’s Disease Treatment Market Segment by Application
11.1 Global Parkinson’s Disease Treatment Revenue Market Share by Application (2014-2019)
11.2 Parkinson’s Disease Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacy Revenue Growth (2014-2019)
11.4 Retail Pharmacy Revenue Growth (2014-2019)
11.5 Online Pharmacy Revenue Growth (2014-2019)
12 Global Parkinson’s Disease Treatment Market Size Forecast (2019-2024)
12.1 Global Parkinson’s Disease Treatment Market Size Forecast (2019-2024)
12.2 Global Parkinson’s Disease Treatment Market Forecast by Regions (2019-2024)
12.3 North America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
12.6 South America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Parkinson’s Disease Treatment Picture
Table Product Specifications of Parkinson’s Disease Treatment
Table Global Parkinson’s Disease Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Parkinson’s Disease Treatment Revenue Market Share by Types in 2018
Figure Oral Picture
Figure Transdermal Picture
Figure Subcutaneous Picture
Figure Intestinal Infusion Picture
Table Global Parkinson’s Disease Treatment Revenue (Million USD) by Application (2014-2024)
Figure Parkinson’s Disease Treatment Revenue Market Share by Applications in 2018
Figure Hospital Pharmacy Picture
Figure Retail Pharmacy Picture
Figure Online Pharmacy Picture
Table Global Market Parkinson’s Disease Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table UCB Basic Information, Manufacturing Base and Competitors
Table UCB Parkinson’s Disease Treatment Type and Applications
Table UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Parkinson’s Disease Treatment Type and Applications
Table AbbVie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Acorda Therapeutics Basic Information, Manufacturing Base and Competitors
Table Acorda Therapeutics Parkinson’s Disease Treatment Type and Applications
Table Acorda Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Parkinson’s Disease Treatment Type and Applications
Table Roche Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Parkinson’s Disease Treatment Type and Applications
Table Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Prothena Basic Information, Manufacturing Base and Competitors
Table Prothena Parkinson’s Disease Treatment Type and Applications
Table Prothena Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Orion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Orion Pharmaceuticals Parkinson’s Disease Treatment Type and Applications
Table Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Impax Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Impax Pharmaceuticals Parkinson’s Disease Treatment Type and Applications
Table Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Voyager Therapeutics Basic Information, Manufacturing Base and Competitors
Table Voyager Therapeutics Parkinson’s Disease Treatment Type and Applications
Table Voyager Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table MSD Basic Information, Manufacturing Base and Competitors
Table MSD Parkinson’s Disease Treatment Type and Applications
Table MSD Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sunovion Basic Information, Manufacturing Base and Competitors
Table Sunovion Parkinson’s Disease Treatment Type and Applications
Table Sunovion Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Intec Pharma Basic Information, Manufacturing Base and Competitors
Table Intec Pharma Parkinson’s Disease Treatment Type and Applications
Table Intec Pharma Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Parkinson’s Disease Treatment Type and Applications
Table GSK Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Acadia Basic Information, Manufacturing Base and Competitors
Table Acadia Parkinson’s Disease Treatment Type and Applications
Table Acadia Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table NeuroDerm Basic Information, Manufacturing Base and Competitors
Table NeuroDerm Parkinson’s Disease Treatment Type and Applications
Table NeuroDerm Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Adamas Therapeutics Basic Information, Manufacturing Base and Competitors
Table Adamas Therapeutics Parkinson’s Disease Treatment Type and Applications
Table Adamas Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Parkinson’s Disease Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue Share by Players (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Share by Players in 2017
Figure Global Parkinson’s Disease Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Parkinson’s Disease Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Parkinson’s Disease Treatment Revenue Market Share in 2018
Figure Global Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Market Share by Regions in 2018
Figure North America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Table North America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
Table North America Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Parkinson’s Disease Treatment Revenue Market Share by Countries in 2018
Figure USA Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Table Europe Parkinson’s Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Parkinson’s Disease Treatment Revenue Market Share by Countries in 2018
Figure Germany Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UK Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure France Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Parkinson’s Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue Market Share by Countries in 2018
Figure China Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure India Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Table South America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
Table South America Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Parkinson’s Disease Treatment Revenue Market Share by Countries in 2018
Figure Brazil Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Parkinson’s Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Share by Type in 2018
Table Global Parkinson’s Disease Treatment Revenue Forecast by Type (2019-2024)
Figure Global Parkinson’s Disease Treatment Market Share Forecast by Type (2019-2024)
Figure Global Oral Revenue Growth Rate (2014-2019)
Figure Global Transdermal Revenue Growth Rate (2014-2019)
Figure Global Subcutaneous Revenue Growth Rate (2014-2019)
Figure Global Intestinal Infusion Revenue Growth Rate (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue by Application (2014-2019)
Table Global Parkinson’s Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue Share by Application in 2018
Table Global Parkinson’s Disease Treatment Revenue Forecast by Application (2019-2024)
Figure Global Parkinson’s Disease Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Parkinson’s Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Parkinson’s Disease Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Parkinson’s Disease Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
Figure Europe Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
Figure South America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
【掲載企業】
UCB、 AbbVie、 Acorda Therapeutics、 Roche、 Teva、 Prothena、 Orion Pharmaceuticals、 Impax Pharmaceuticals、 Voyager Therapeutics、 MSD、 Sunovion、 Intec Pharma、 GSK、 Acadia、 NeuroDerm、 Adamas Therapeutics
